加科思药业集团有限公司（01167）于2026年2月5日发布了2026年1月份的股份变动月报表。报告显示，公司法定股本维持在1,000,000,000股普通股，面值每股USD0.0001，注册股本总额为USD100,000。期末总已发行股本（含库库存股份）为791,755,080股，较上月底并无增减变动。
\n\n根据公告，报告期内公司回购390,000股普通股，分别于2026年1月2日及1月6日购回150,000股及240,000股，回购价格分别为每股HKD6.44及HKD6.19。受此影响，公司1月底的已发行股份（不含库存股份）减少至786,672,780股，相比期初减少390,000股；同期库存股份增加至5,082,300股。
\n\n公司在公告中确认，其公众持股量符合香港联合交易所相关上市规则的最低要求。截至报告期末，总股本保持不变，已发行股份和库存股份之间的结构有所调整。公告由董事王晓洁签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.